Summary of Clarivate Conference Call Company Overview - **Company**: Clarivate (NYSE: CLVT) - **Date of Conference**: November 19, 2025 Key Industry Insights - **Industry Focus**: Information services, particularly in academic, life sciences, and intellectual property (IP) sectors - **Core Technology**: Emphasis on proprietary data and AI integration Core Points and Arguments 1. **Generative AI Impact**: Clarivate views generative AI as an opportunity rather than a threat, leveraging its proprietary data that cannot be replicated by public AI systems [4][5][6] 2. **Proprietary Data**: The company emphasizes its unique data assets across segments, including bibliometric databases and proprietary analytics, which are deeply embedded in client workflows [5][6][7] 3. **AI Innovations**: Clarivate is actively deploying AI across its products, enhancing existing offerings and introducing new AI-driven products, such as RiskMark and Web of Science Research Intelligence [8][15] 4. **Investment Strategy**: Current capital spending is deemed adequate, with a focus on AI-driven product development and operational efficiencies expected to enhance margins in the future [11][12] 5. **Subscription Growth**: The company has increased its subscription revenue from 80% to 88% of organic revenue, with plans to reach 90% [16][18] 6. **Renewal Rates**: Improvement in renewal rates from 92% to 93% attributed to product investments and enhanced customer success initiatives [14][20] 7. **Market Growth Projections**: Clarivate anticipates growth in the ANG market at 3%-4%, with life sciences showing mid-single-digit growth potential [21][22][30] 8. **IP Market Recovery**: New patent filings increased by 5%, indicating a recovery in the IP market, which is expected to benefit Clarivate's annuity business [24][25] 9. **Competitive Positioning**: Clarivate maintains a unique market position with a comprehensive suite of products that competitors cannot match [26] Additional Important Insights - **Geographic Stability**: The company reports stable budgets across major geographies, with encouraging performance in North America [29] - **Life Sciences Transition**: The life sciences segment is transitioning towards a higher percentage of subscription revenue, currently at 85% [32] - **Cash Flow and Capital Allocation**: Clarivate has robust free cash flow generation, with balanced capital allocation strategies including stock repurchases and debt reduction [36][37] This summary encapsulates the key points discussed during the Clarivate conference call, highlighting the company's strategic focus on AI, proprietary data, and subscription growth while navigating market dynamics and competitive positioning.

Core Insights - Clarivate Plc, a leading global provider of transformative intelligence, will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 19, 2025 [1][3] - The presentation will be led by Matt Shem Tov, Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer [1] - A live webcast of the presentation will be available and can be accessed online, with a replay option available for 90 days [2] Company Overview - Clarivate offers enriched data, insights, analytics, workflow solutions, and expert services across various sectors including Academia & Government, Intellectual Property, and Life Sciences & Healthcare [3]

Core Insights - Clarivate Plc has released the Highly Cited Researchers 2025 list, recognizing researchers with significant influence in their fields [1][2] - The list highlights the concentration of top research talent globally, with 86% of awards concentrated in just 10 countries/regions [7] Group 1: Global Research Landscape - A total of 6,868 individuals received 7,131 awards from over 1,300 institutions across 60 countries and regions [2] - The United States leads with 2,670 awards, accounting for 37.4% of the global total, showing a 1% increase from 2024 [5][7] - Mainland China follows with 1,406 awards (19.7%), experiencing a slight decrease in global share by 0.7% [5][7] - The United Kingdom ranks third with 570 awards (8%), while Germany, Australia, and Canada follow with 363, 312, and 227 awards respectively [5][7] Group 2: Institutional Recognition - The Chinese Academy of Sciences (CAS) is the top institution with 258 awards, followed by Harvard University (170) and Stanford University (141) [8] - Notably, the National Institutes of Health (NIH) and Massachusetts Institute of Technology (MIT) also feature prominently with 84 and 85 awards respectively [8] Group 3: Evaluation and Integrity - The Highly Cited Researchers program has enhanced its evaluation process to address issues like hyper-prolific authorship and self-citation, excluding 432 potential awards this year [10] - The program aims to uphold high standards of research integrity while recognizing individual achievements that have a broad and significant influence [4][10]

Core Insights - Kenneth L. Cornick, a board member of Clarivate Plc, purchased 725,000 shares valued at approximately $2.5 million, increasing his total ownership to 1,032,711 shares post-transaction [1][2][6] Transaction Summary - Total shares purchased in open-market transactions amounted to 725,000 [2] - The transaction value was approximately $2.5 million, based on a weighted average purchase price of $3.42 per share [2] - Post-transaction, direct ownership was 32,711 shares, while indirect ownership totaled one million shares [6] - The transaction represented a small fraction of Clarivate's market capitalization of $2.28 billion as of November 3, 2025 [6] Company Overview - Clarivate's stock price was $3.54 as of market close on November 3, 2025, with a market capitalization of $2.28 billion and a revenue of $2.50 billion for the trailing twelve months [4] - The company experienced a 1-year price change of -26.28% as of the reference date [4] Company Performance - Clarivate reported Q3 revenue of $623.1 million, slightly above the previous year's $622.2 million, but total sales for the first three quarters were down 3% year-over-year to $1.9 billion [10] - The company had a significant debt of $4.5 billion at the end of Q3, with cash and equivalents amounting to $318.7 million [11] - Clarivate reported a Q3 net loss of $28.3 million, an improvement from a loss of $65.6 million in the prior year [11] Market Context - The purchase by Cornick occurred during a period of declining stock prices, with shares down from a 52-week high of $5.88 reached last December [9] - The transaction suggests a bullish outlook from Cornick despite the company's recent performance challenges and high debt levels [12]

Core Insights - Clarivate Plc announced that FUJIFILM Holdings Corporation has selected IPfolio, a cloud-based intellectual property management platform, to enhance its IP operations and support business growth [1][2]. Group 1: Company Strategy - FUJIFILM aims to transform its IP operations by implementing a scalable data infrastructure and integrating various internal and external tools through IPfolio [3]. - The use of IPfolio will allow FUJIFILM to consolidate its IP operations across diverse business segments into a single platform, enhancing efficiency and decision-making [2][3]. Group 2: Industry Impact - Clarivate emphasizes its commitment to improving IP management efficiency for its customers, showcasing how its solutions can contribute to enhancing corporate value [3].

Core Viewpoint - The analyst previously held a buy rating for Clarivate (CLVT), believing the business was on a positive trajectory, especially with the stock trading at approximately 6x forward PE [1] Group 1: Investment Philosophy - The investment approach is fundamentally driven, focusing on identifying businesses with potential for long-term scaling and significant terminal value [1] - Key factors considered include competitive moat, unit economics, reinvestment opportunities, and management quality, which are essential for long-term free cash flow generation and shareholder value creation [1] - The analyst emphasizes the importance of fundamental research and targets sectors with strong secular tailwinds [1] Group 2: Professional Background - The analyst has 10 years of experience in investment banking and is currently managing personal funds sourced from friends and family [1] - The motivation for writing on Seeking Alpha is to share investment insights and receive feedback from other investors [1] - The aim is to help readers focus on the drivers of long-term equity value, advocating for analysis that is both analytical and accessible [1]

Core Insights - The "Pulse of the Library 2025" report by Clarivate highlights how libraries are adapting to rapid changes, including AI adoption, open science, and geopolitical pressures [1][5]. AI Adoption - There is a steady rise in AI adoption among libraries, with 67% exploring or implementing AI tools, up from 63% in 2024 [2]. - Libraries with AI literacy as part of training programs are more likely to be in moderate or active implementation phases, with 28% reporting this factor [3]. - Senior librarians show greater confidence in AI terminology, with 43% rating their confidence as 4 or 5 on a scale of 1 to 5, compared to 36% of junior librarians [7]. Regional Variations - AI adoption varies regionally, with 37-40% of libraries in Asia and Europe in initial implementation or beyond, compared to 14-16% in 2024 [7]. - The U.S. lags in AI adoption and confidence, with only 7% optimistic about AI's potential benefits, compared to 27-31% in Asia and other regions [7]. Library Missions and Challenges - Core library missions remain mostly unchanged from 2024, with a notable shift in academic libraries focusing on student engagement as a primary objective in 2025 (40%) [7]. - Budget constraints are a significant challenge, with half of U.S. and North American respondents expecting cuts to collections due to geopolitical pressures [7]. Survey Demographics - The report is based on insights from over 2,000 librarians across 109 countries, with 77% representing academic libraries and 46% of respondents located in the U.S. [5][8].

Core Insights - Clarivate PLC reported revenue of $623.1 million for the quarter ended September 2025, reflecting a slight increase of 0.1% year-over-year and exceeding the Zacks Consensus Estimate by 9.23% [1] - The company's EPS was $0.18, down from $0.19 in the same quarter last year, but still surpassed the consensus estimate of $0.16 by 12.5% [1] Revenue Breakdown - Intellectual Property revenues were $197.8 million, slightly above the average estimate of $191.24 million, but down 1% year-over-year [4] - Academia & Government revenues reached $332.5 million, significantly exceeding the average estimate of $288.24 million, with a year-over-year increase of 3.5% [4] - Life Sciences & Healthcare revenues totaled $92.8 million, below the average estimate of $94.26 million, marking an 8.2% decline year-over-year [4] - Re-occurring revenues were reported at $105.3 million, slightly below the average estimate of $106.89 million, reflecting a year-over-year decrease of 1.3% [4] - Subscription revenues amounted to $405.4 million, also below the average estimate of $409.61 million, with a year-over-year decline of 1.4% [4] - Transactional revenues were $112.4 million, significantly above the estimated $58.23 million, showing a year-over-year increase of 7.7% [4] Stock Performance - Over the past month, Clarivate's shares have returned -5%, contrasting with the Zacks S&P 500 composite's increase of 3.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Financial Data and Key Metrics Changes - Q3 revenue was $623 million, essentially flat compared to the same period last year, bringing year-to-date revenue to $1.84 billion [17] - The third quarter net loss was $28 million, an improvement driven by higher foreign exchange gains and the absence of a non-cash impairment charge recorded last year [17] - Adjusted diluted EPS was flat sequentially at $0.18, with changes attributed to the divestiture of ScholarOne [17] - Free cash flow was $115 million in Q3, totaling $276 million year-to-date, driven by adjusted EBITDA and working capital [22] Business Line Data and Key Metrics Changes - The A&G segment saw a 2% ACV growth, with a subscription mix now at 93% compared to 81% last year [7][8] - The Intellectual Property segment's recurring revenue was flat year-to-date, representing a 3% improvement in organic growth compared to the full year of 2024 [9] - Life Sciences and Health segment returned to 2% ACV growth, driven by new product introductions and AI integration [11] Market Data and Key Metrics Changes - The company secured over 100 contracts for its new content subscription framework, indicating strong market demand [8] - Renewal rates in Life Sciences and Health improved to 93%, up 100 basis points year-over-year [5] - The U.S. dollar remained weaker against foreign currencies, providing a foreign exchange tailwind on revenue [20] Company Strategy and Development Direction - The company is focused on executing its value creation plan, emphasizing product and AI development to drive organic growth [6][14] - Plans to streamline the business model and market focus include exiting A&G transactional books and the Life Sciences Real World Data Resell Market [15] - The company aims to enhance its core subscription and recurring revenue mix to improve predictability, achieving an 8% improvement this year compared to last year [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning the Intellectual Property segment to sustainable growth under new leadership [9][35] - The company anticipates continued acceleration in organic annual contract value and expects to raise revenue guidance by $50 million [24] - Management believes that operational efficiency and margin expansion will be achieved through the adoption of agentic AI [14] Other Important Information - The company has completed $150 million in share repurchases year-to-date and paid down $100 million in debt [5][23] - The strategic disposals are expected to lower revenue by approximately $90 million this year, with a similar impact anticipated next year [28] Q&A Session Summary Question: Insights on the patent renewal business and competitive landscape - Management noted that the patent and trademark renewal service declined by about 3% last year but is now flat year-to-date, with expectations for improvement under new leadership [35][36] Question: Updates on new innovations in the value creation plan - Management highlighted the introduction of AI-enabled products and a renewed focus on product innovation, with several new products expected to drive growth [41][42] Question: Impact of large ebook transactions on revenue and EBITDA - Management indicated that multiple large ebook transactions positively impacted revenue, with expectations for a decline in that area moving forward [47] Question: Potential of the business after strategic changes - Management expressed optimism about returning to market growth rates of 3-4% over time, citing strong fundamentals and a supportive customer base [48][49] Question: ACV acceleration and segment contributions - Management noted improvements across all segments, particularly in Life Sciences, with expectations for continued growth in the IP segment [55] Question: Trends in patents and trademarks - Management observed a gradual increase in patents in force and anticipated a recovery in volumes driven by innovation, particularly in AI [61][62] Question: Transactional revenues and their impact on guidance - Management explained that slower attrition of disposals contributed to improved revenue guidance, with a significant portion of revenue expected to decline next year [72]

Financial Data and Key Metrics Changes - Q3 revenue was $623 million, essentially flat compared to the same period last year, bringing year-to-date revenue to $1.84 billion [17] - The third quarter net loss was $28 million, an improvement driven by higher foreign exchange gains and the absence of a non-cash impairment charge recorded last year [17] - Adjusted diluted EPS was flat sequentially at $0.18, with changes attributed to the divestiture of ScholarOne [17] - Free cash flow was $115 million in Q3, totaling $276 million year-to-date, driven by adjusted EBITDA and working capital [22] Business Line Data and Key Metrics Changes - In the A&G segment, there was a 2% ACV growth, with a subscription mix now at 93% compared to 81% last year [7][8] - The Intellectual Property segment's recurring revenue was flat year-to-date, but showed a 3% improvement in organic growth rate compared to the full year of 2024 [9] - The Life Sciences and Health segment returned to 2% ACV growth, driven by new product introductions and AI integration [11] Market Data and Key Metrics Changes - The company secured over 100 contracts for its new content subscription framework, indicating strong market demand [8] - Renewal rates in the A&G segment were strong, with 90% of global subscriptions successfully renewed through October 27 [8] - The overall patents in force in core markets are expected to grow, indicating a potential recovery in the IP market [60] Company Strategy and Development Direction - The company is focused on executing its value creation plan, emphasizing product and AI development to drive organic growth [6][14] - There is a commitment to optimizing the business model by increasing the core subscription and recurring revenue mix [7] - The company is streamlining its business model by exiting non-core areas and focusing on strategic alternatives [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning the IP segment to sustainable growth under new leadership [9][34] - The company anticipates continued acceleration in organic annual contract value and recurring organic growth in the upper half of its guidance range [24] - There is optimism regarding the impact of AI on future growth, with expectations of a market recovery in the coming years [60] Other Important Information - The company has completed $150 million in share repurchases year-to-date and paid down $100 million in debt [5][23] - The company expects to maintain a balanced capital allocation strategy while investing in product innovation [30] Q&A Session Summary Question: Insights on the patent renewal business and competitive landscape - Management noted that the patent and trademark renewal service declined by about 3% last year but is now flat year-to-date, with expectations for improvement under new leadership [34] Question: Updates on the value creation plan and new innovations - Management highlighted the introduction of new AI-enabled products and a renewed focus on product innovation as key components of the value creation plan [42] Question: Impact of large ebook transactions on revenue and EBITDA - Multiple large ebook transactions positively impacted revenue in Q3, with expectations for a slower decline in disposals than previously anticipated [46][68] Question: Trends in the IP market and catalysts for recovery - Management indicated that the overall patents in force are expected to grow, with AI innovation likely to boost renewal volumes in the coming years [60] Question: AI initiatives and proprietary content - The majority of AI innovations support information services, with significant proprietary data being utilized to enhance product offerings [62]